Professional Documents
Culture Documents
1 Lesson Plan
9 Cancer Medicine (Oncology)
TEACHING FOCUS
Students will have the opportunity to gain familiarity with terms that describe the classifications of tumors
and those terms related to the causes, diagnoses, and treatment of cancer. The laboratory tests that are used to
determine not only the presence of a tumor but the degree to which it has spread also will be described in
this chapter. Finally, abbreviations and terms associated with the care of cancer patients will also be
presented in this chapter.
LESSON CHECKLIST
KEY TERMS
encapsulated
external beam radiation
fractionation
genetic screening
grading of tumors
gray (Gy)
gross description of tumors
infiltrative
invasive
linear accelerator
malignant tumor
mesenchymal
metastasis
microscopic description (of tumors)
mitosis
mixed-tissue tumors
modality
molecularly targeted drugs
morbidity
mucinous
mutation
relapse
remission
ribonucleic acid (RNA)
sarcoma
serous
sessile
solid tumor
staging of tumors
steroids
surgical procedures to treat cancer
tumors
ultraviolet radiation
viral oncogenes
virus
polyp/o
prot/o
radi/o
sarc/o
scirrh/p
xer/o
-blastoma
Legend
CD
Companion CD
iTerms
IRM
Instructors
Resource Manual
available on CD
and Evolve
fibr/o
follicul/o
fung/i
medull/o
mucos/o
mut/a
mutagen/o
necr/o
onc/o
papill/o
pharmac/o
plas/o
ple/o
REFERENCE LIST
PowerPoint slides (CD, Evolve): 1-40
Evolve
Evolve
Resources
PPT
PowerPoint
Slides
MTO
Medical
Terminology
Online
-genesis
-oma
-plasia
-plasm
-suppression
-therapy
anaapobrachyepimetatele-
LESSON 19.1
PRETEST
IRM Exercise Quiz B
BACKGROUND ASSESSMENT
Question: The term neoplasm refers to tumors that are masses or growths that arise from normal tissue. A
growth can occur at any time in life. Are all neoplasms life threatening?
Answer: The term neoplasm refers to the growth. Neoplasms may be either malignant or benign. Benign
growths are noninvasive and do not spread to other sites. They can be life threatening if their removal would
be difficult and destroy other important organs (as with some benign brain tumors). Malignant tumors
compress, invade, and ultimately destroy surrounding tissues. They spread to other sites and are life
threatening.
Question: There are agents in the environment that, upon exposure, are known to increase an individuals
risk of developing cancer. What are some of those environmental agents, and how do they contribute to
increasing cancer risk?
Answer: Environmental agents that contribute to cancer risk do so by damaging the genetic material in cells
that regulate growth, division, and protein synthesis. They cause chemical changes in the nucleotide
components of the cells DNA and get passed on to daughter cells. They affect not only cell growth, but
also cell repair and the ability of a cell to know when to die or disintegrate (apoptosis). Some of these
environmental agents include chemicals in cigarettes, automobile exhaust, insecticides, dyes, industrial
chemicals, insulation, and hormones. Radiation also contributes to cancer risk in the form of sunlight, x-rays,
radioactive substances, and nuclear fission. Viruses in the environment may also be carcinogenic because of
their ability to transform cells and alter their genetic material.
OBJECTIVES
Learn medical
terms that
describe the
growth and
spread of
tumors.
CONTENT
TEACHING RESOURCES
PPT 5-10
MTO Module 19, Section I, Lesson 1
Figure 19-1 A, Photomicrograph of normal
skeletal muscle cells; B, Anaplastic tumor cells
of the skeletal muscle (p. 794)
Figure 19-2 A liver studded with metastatic
cancer (p. 795)
Figure 19-3 Differences between benign and
malignant tumors (p. 795)
Exercise A (p. 827)
Have groups of three develop
a list of characteristics of tumors, both
benign and malignant. Pick a group to
present the description. Have the class offer
improvements.
Class Activity
OBJECTIVES
CONTENT
TEACHING RESOURCES
Have students interview family
members and other students about their daily
exposure to carcinogens. Students should ask
what they have done to prevent cancer
(e.g., wear SPF sunscreen). Have students
report their findings in class. See whether
males and females engage in different
preventative behaviors and whether they
think males or females are exposed to more
carcinogens.
Class Activity
Become familiar
with terms
related to the
causes,
diagnosis, and
treatment of
cancer.
PPT 11-13
MTO Module 19, Section I, Lesson 2
Figure 19-4 Two functions of DNA (p. 796)
Figure 19-5 Chromosomal (oncogene)
translocation (p. 798)
Table 19-1 Genes implicated in hereditary
cancers (p. 799)
Figure 19-6 Role of environmental agents and
heredity in carcinogenesis (p. 799)
Exercise B (p. 827)
Discuss Table 19-1 regarding how risk of
cancer can be inherited through suppressor
genes and how genes can be analyzed for risk.
Divide the class into two
competing teams. Give each team a set of
different flash cards with the names of cancer
treatments on them. The teams take turns
showing a card to the opponent, who has to
define or describe the treatment. The correct
answer wins a point. However, the first team
loses a point for accepting an incorrect
answer or rejecting a correct answer. The
team with the most points wins.
Class Activity
Recognize how
tumors are
classified and
described by
pathologists.
PPT 14-20
Table 19-2 Carcinomas and the epithelial
tissues from which they derive (p. 800)
Table 19-3 Sarcomas and the connective
tissues from which they derive (p. 801)
Table 19-4 Mixed-tissue tumors (p. 802)
OBJECTIVES
CONTENT
TEACHING RESOURCES
Exercise C (p. 828)
Discuss Tables 19-2 and 19-3 with respect to
the tissues from which carcinomas and
sarcomas derive.
Have students cut out paper
images of chromosomes and go over how
replication and cell division create daughter
cells (mitosis) and how germ cells are created
(meiosis). Then have two groups explain at
what point carcinogens can thwart the
process of cell division. Have another group
explain how mutations lead to damaged DNA
and malignancy. This group should focus on
other cell processes besides division (e.g.,
protein synthesis, programmed cell death).
Class Activity
Have students research cancer survival rates and treatments for men vs. women.
LESSON 19.2
CRITICAL THINKING QUESTION
Dr. Duke is an oncologist. He recently biopsied tissue from a tumor on Saras face. He told her that her
tumor is malignant but that it still looks very much like its parent tissue. He also told her that T is less
than one, N is zero, and M is zero. What can she tell about her prognosis from this information?
Guidelines: Her prognosis is very good. Her cancer is treatable and caught in its early stages, so her chances
of long-term survival are very high. The tissue looks much like its original form; thus, it is still well
differentiated and in its early stages of transformation. T refers to the size of the tumor, N refers to the
number of lymph nodes that are invaded, and M refers to metastases to other organs. Her biopsy report
indicates that her tumor is small, differentiated, and has not spread. This is good for treatment and prognosis.
OBJECTIVES
Recognize how
tumors are
classified and
described by
pathologists.
CONTENT
Microscopic descriptions
(p. 803)
TEACHING RESOURCES
PPT 22-26
MTO Module 19, Section II, Lessons 1-2
Figure 19-7 A, Cystic ovarian adenocarcinoma;
B, medullary carcinoma (p. 802)
Figure 19-8 A, Adenomatous polyposis; B,
Gastric carcinoma (p. 803)
Figure 19-9 A, Follicular non-Hodgkin
lymphoma; B, Papillary carcinoma (p. 804)
Exercises D, E (p. 828-829)
Give small groups copies of
actual pathology reports. Have them find
terms for gross and microscopic pathological
descriptions and define them. Have them
share their findings with the class.
Class Activity
an atlas of microscopic
pathology, divide the class into groups. Assign
each group a cancer of a particular organ
system. Have students pick out micrographs
of their disease category, and then find
micrographs of healthy organ systems using a
medical atlas of histology. Have the students
point out the most obvious differences in the
structure of the diseased versus healthy
organ. See an example of a similar
comparison in the text, Figure 19-1.
Understand the
PPT 28-30
OBJECTIVES
CONTENT
x-rays,
laboratory tests,
and procedures
used by
physicians for
determining the
presence and
extent of spread
(staging) of
tumors.
(p. 804)
TEACHING RESOURCES
Table 19-5 International TNM staging system
for lung cancer (p. 805)
Exercise F (p. 829)
Class Activity Have
Have students investigate cancer registries: Which hospitals in the area have them? What is their purpose?
Cancer is a reportable disease. If there is no registry, who receives and compiles reports?
Ask students to explore the National Cancer Registrars Web site (http://www.ncra-usa.org) to find out more
about the career of cancer registry/oncology data registrars.
10
LESSON 19.3
CRITICAL THINKING QUESTION
Lois has been notified that she must undergo surgery to remove a malignant growth from her uterus.
She asks her doctor whether she will need adjuvant therapy after her surgery. Her doctor tells her she
will know that only after the surgery. What sorts of information might her doctor obtain from the
surgery to determine whether she needs additional treatment?
Guidelines: Loiss doctor will try to determine whether her tumor has spread beyond the tissue she plans to
remove. If it is early, the doctor may find that she can remove the entire tumor, and surgery alone might cure
Loiss cancer. A debulking procedure may be used if the tumor is attached to a vital organ and cannot be
completely removed. In that case, her doctor will remove as much tissue as possible with additional radiation
or chemotherapy needed later. Her doctor will do what is called an excisional biopsy that will be used for
diagnosis but might also be curative.
OBJECTIVES
Recognize
procedures,
tests, and
abbreviations
that pertain to
the care of
cancer patients.
CONTENT
TEACHING RESOURCES
PPT 32-36
MTO, Module 19, Section II, Lessons 3-4
Figure 19-10 Linear accelerator (p. 807)
Figure 19-11 Proton therapy machine (p.808)
Figure 19-12 Hodgkins disease before and
after radiation therapy (p. 809)
Table 19-6 Selected cancer chemotherapeutic
agents and the cancers they treat (p. 811)
Figure 19-13 Mechanisms of action of cancer
chemotherapeutic agents (p. 813)
Table 19-7 Cancers and chemotherapeutic
regimens (p. 812)
Table 19-8 Biological agents and their modes
of action (p. 814)
Table 19-9 Newest anticancer drugs and their
modes (p. 814)
Exercises G-I (pp. 830-831)
Invite a spokesperson from a
local cancer group to speak to the class about
his or her organization. A cancer survivor
might also discuss the disease and treatment.
Class Activity
Class Activity
OBJECTIVES
CONTENT
11
TEACHING RESOURCES
groups and have each choose a contestant for
a quiz show. Using transparencies or
flashcards, show the contestants a variety of
words one at a time. Ask them to pronounce
each word correctly and define it. The first
contestant to answer correctly wins a point.
When a contestant answers incorrectly, the
team chooses a new contestant.
Class Activity Use
19.3 Homework/Assignments:
12
LESSON 19.4
CRITICAL THINKING QUESTION
Why do some cancer chemotherapeutic agents, such as antimetabolites, have noxious side effects in
certain organ systems? What other classes of cancer chemotherapy might have similar treatment
effects?
Guidelines: Drugs that target quickly dividing tumor cells attach to DNA molecules to disrupt DNA
synthesis or block replication to kill the cells. Cells in the body that normally divide often also take up these
drugs. These include cells that form blood and hair elements and which line the intestine. The drug is meant
to disrupt cell duplication; alopecia (hair loss), myelosuppression (bone marrow depression), and
gastrointestinal distress (nausea) are common side effects. Alkylating agents, antimitotics, and
antimetabolites all have toxic side effects because they work on quickly dividing cells via these similar
mechanisms.
OBJECTIVES
Recognize
procedures,
tests, and
abbreviations
that pertain to
the care of
cancer patients.
CONTENT
TEACHING RESOURCES
PPT 37-39
MTO Module 19, Section I, Lessons 3-4
Figure 19-14 (A) Normal smear from the
cervicovaginal region; (B) Abnormal
cervicovaginal smear (p. 822)
Exercises J-K (pp. 831-832)
Divide the class into two
competing teams. Show them a flash card,
transparency, or PowerPoint slide of an
abbreviation. Ask them to provide the term it
stands for. The first team to give a correct
answer wins a point. Give an additional point
for a definition of the term.
Class Activity
Performance
OBJECTIVES
CONTENT
Evaluation
TEACHING RESOURCES
MTO Module 19, Sections I-II quizzes
MTO Module 19 Exam.
iTerms Chapter 19
19.4 Homework/Assignments:
Have students look up chemotherapeutic agents and report back on the side effects of these agents. Assign
groups to different types of cancer (such as gastric sarcoma and melanoma). What are the available drugs to
help patients deal with their side effects? Are there many? How do they work?
13